The FDA rejected Moderna's application for its mRNA flu vaccine, citing concerns over the design of its pivotal clinical trial,…
Read More »Moderna
Entity category: organization
A personalized mRNA vaccine combined with standard immunotherapy nearly halved the risk of recurrence or death in high-risk melanoma patients…
Read More »
Biotechnology and scientific research are essential for developing next-generation medical solutions and building resilient global health systems, as emphasized by…
Read More »
Moderna's CEO criticized new federal health policies that restrict COVID-19 vaccine eligibility, arguing they create confusion and reduce public access…
Read More »
Moderna's mRNA flu vaccine showed 27% better protection than traditional flu shots in a phase 3 trial with 41,000 participants,…
Read More »